Disease‐related changes were relatively similar in AD‐tau/sham and AD‐tau/Aβ groups, confirming neuropathological findings suggesting that oligomeric Aβ injections had a few impacts on early tau pathology development. Here, MAPT is linked to Alzheimer disease.